These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 24360309

  • 21. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
    Cullen M, Steven N, Billingham L, Gaunt C, Hastings M, Simmonds P, Stuart N, Rea D, Bower M, Fernando I, Huddart R, Gollins S, Stanley A, Simple Investigation in Neutropenic Individuals of the Frequency of Infection after Chemotherapy +/- Antibiotic in a Number of Tumours (SIGNIFICANT) Trial Group.
    N Engl J Med; 2005 Sep 08; 353(10):988-98. PubMed ID: 16148284
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
    Laoprasopwattana K, Khwanna T, Suwankeeree P, Sujjanunt T, Tunyapanit W, Chelae S.
    Pediatr Infect Dis J; 2013 Mar 08; 32(3):e94-8. PubMed ID: 23080291
    [Abstract] [Full Text] [Related]

  • 24. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
    Mullen CA.
    Pediatr Infect Dis J; 2003 Dec 08; 22(12):1138-42. PubMed ID: 14688588
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
    Delarive P, Baumgartner JD, Glauser MP, Cometta A.
    Schweiz Med Wochenschr; 2000 Dec 02; 130(48):1837-44. PubMed ID: 11132527
    [Abstract] [Full Text] [Related]

  • 27. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I, Sanz MA.
    Enferm Infecc Microbiol Clin; 1999 Dec 02; 17 Suppl 2():95-102. PubMed ID: 10605194
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Predicting the risk of severe bacterial infection in children with chemotherapy-induced febrile neutropenia.
    Macher E, Dubos F, Garnier N, Delebarre M, De Berranger E, Thebaud E, Mazingue F, Leblond P, Martinot A.
    Pediatr Blood Cancer; 2010 Oct 02; 55(4):662-7. PubMed ID: 20806364
    [Abstract] [Full Text] [Related]

  • 32. Audit of fluoroquinolone prophylaxis against chemotherapy-induced febrile neutropenia in a hospital with highly prevalent fluoroquinolone resistance.
    Ng ES, Liew Y, Earnest A, Koh LP, Lim SW, Hsu LY.
    Leuk Lymphoma; 2011 Jan 02; 52(1):131-3. PubMed ID: 20929324
    [No Abstract] [Full Text] [Related]

  • 33. Fluoroquinolone prophylaxis against febrile neutropenia in areas with high fluoroquinolone resistance--an Asian perspective.
    Ng ES, Liew Y, Koh LP, Hsu LY.
    J Formos Med Assoc; 2010 Sep 02; 109(9):624-31. PubMed ID: 20863989
    [Abstract] [Full Text] [Related]

  • 34. Impact of fluoroquinolone prophylaxis during neutropenia on bloodstream infection: Data from a surveillance program in 8755 patients receiving high-dose chemotherapy for haematologic malignancies between 2009 and 2014.
    Kern WV, Weber S, Dettenkofer M, Kaier K, Bertz H, Behnke M, Weisser M, Götting T, Widmer AF, Theilacker C, Hospital Infection Surveillance System for Patients with Haematologic/Oncologic Malignancies Study Group (ONKO-KISS).
    J Infect; 2018 Jul 02; 77(1):68-74. PubMed ID: 29883599
    [Abstract] [Full Text] [Related]

  • 35. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
    Leibovici L, Paul M, Cullen M, Bucaneve G, Gafter-Gvili A, Fraser A, Kern WV.
    Cancer; 2006 Oct 15; 107(8):1743-51. PubMed ID: 16977651
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Prophylaxis with ciprofloxacin in postchemotherapy neutropenia in acute myeloid leukemia].
    López A, Soler JA, Juliá A, Novo A, Bueno J.
    Med Clin (Barc); 1994 Jan 29; 102(3):81-5. PubMed ID: 8133717
    [Abstract] [Full Text] [Related]

  • 38. Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropenia.
    Wingard JR, Eldjerou L, Leather H.
    Curr Opin Hematol; 2012 Jan 29; 19(1):21-6. PubMed ID: 22080847
    [Abstract] [Full Text] [Related]

  • 39. Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia.
    Hammond SP, Baden LR.
    Curr Hematol Malig Rep; 2007 May 29; 2(2):97-103. PubMed ID: 20425357
    [Abstract] [Full Text] [Related]

  • 40. Febrile neutropenia: highlighting the role of prophylactic antibiotics and granulocyte colony-stimulating factor during standard dose chemotherapy for solid tumors.
    Timmer-Bonte JN, Tjan-Heijnen VC.
    Anticancer Drugs; 2006 Sep 29; 17(8):881-9. PubMed ID: 16940798
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.